Evidence map›Paper›PMID 19463978›Full record

ArticleBone2009

NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation.

Min-Kyung Choo, Hyeonju Yeo, Majd Zayzafoon

Abstract read
In one paragraph

Article in Bone, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Enhanced Osteogenic Potential ofACS biomaterials science & engineering · 2023
    Article
  7. Article
  8. Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.International journal of molecular sciences · 2022
    Review
  9. Article
  10. The role of CaCell proliferation · 2021
    Review
  11. Article
  12. The Roles of Epigenetics Regulation in Bone Metabolism and Osteoporosis.Frontiers in cell and developmental biology · 2020
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Concise Review: Stem Cells in Osteoimmunology.Stem cells (Dayton, Ohio) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Min-Kyung ChooDepartment of Pathology, University of Alabama at Birmingham, 813 Shelby Biomedical Research Building, 1825 University Boulevard, Birmingham, AL 35294, USA.
Hyeonju Yeo
Majd Zayzafoon
University of Alabama at Birmingham · USAmorepacific (South Korea) · KR

Funding

The Role of Transcription Factor NFAT in Osteoblast DifferentiationR01AR053898 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZAYZAFOON, MAJD · 2007 to 2011
$1.5M
NIAMS NIH HHS R01 AR053898NIAMS NIH HHS R01-AR053898
6 · The paper itself

Abstract

We previously reported that the in vivo and in vitro suppression of Nuclear Factor of Activated T Cells (NFAT) signaling increases osteoblast differentiation and bone formation. To investigate the mechanism by which NFATc1 regulates osteoblast differentiation, we established an osteoblast cell line that overexpresses a constitutively active NFATc1 (ca-NFATc1). The activation of NFATc1 significantly inhibits osteoblast differentiation and function, demonstrated by inhibition of alkaline phosphatase activity and mineralization as well as a decrease in gene expression of early and late markers of osteoblast differentiation such as osterix and osteocalcin, respectively. By focusing on the specific role of NFATc1 during late differentiation, we discovered that the inhibition of osteocalcin gene expression by NFATc1 was associated with a repression of the osteocalcin promoter activity, and a decrease in TCF/LEF transactivation. Also, overexpression of NFATc1 completely blocked the decrease in total histone deacetylase (HDAC) activity during osteoblast differentiation and prevented the hyperacetylation of histones H3 and H4. Mechanistically, we show by Chromatin Immunoprecipitation (ChIP) assay that the overexpression of NFATc1 sustains the binding of HDAC3 on the proximal region of the osteocalcin promoter, resulting in complete hypoacetylation of histones H3 and H4 when compared to GFP-expressing osteoblasts. In contrast, the inhibition of NFATc1 nuclear translocation either by cyclosporin or by using primary mouse osteoblasts with deleted calcineurin b1 prevents HDAC3 from associating with the proximal regulatory site of the osteocalcin promoter. These preliminary results suggest that NFATc1 acts as a transcriptional co-repressor of osteocalcin promoter, possibly in an HDAC-dependent manner.

Indexed as

AnimalsAntigens, DifferentiationCalcineurinCell DifferentiationCell NucleusHistone Deacetylase 3Histone DeacetylasesMiceNFATC Transcription FactorsOsteoblastsOsteocalcinPromoter Regions, GeneticProtein TransportSp7 Transcription FactorTranscription FactorsTranscription, GeneticAntigens, DifferentiationCalcineurinHistone Deacetylase 3Histone DeacetylasesNfatc1 protein, mouseNFATC Transcription FactorsOsteocalcinSp7 protein, mouseSp7 Transcription FactorTranscription Factors

Identifiers

PMID19463978
PMCPMC2732115
OpenAlexW1979017313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.